Braskem S.A. (BAK) AI Stock Analysis

Braskem S.A. is a producer of thermoplastic resins operating across Brazil, the United States and Europe, and Mexico. In Brazil, its portfolio features chemicals such as ethylene and propylene, fuels, and specialty products including isoprene, hydrocarbon resins, and green polyethylene made from renewable sources. In the United States and Europe, Braskem focuses on polypropylene manufacturing. In Mexico, the company produces ethylene and polyethylene for industrial sectors. Braskem also supplies industrial utilities such as steam, water, and industrial gases to support manufacturing operations.

Braskem's revenue contracted from $105.62B in FY2021 to $69.33B in FY2025, representing a 5-year revenue CAGR of 3.4% from FY2020 to FY2025. Annual net income declined from $13.98B in FY2021 to net losses of -$336.0M in FY2022, -$4.58B in FY2023, -$11.32B in FY2024, and -$9.69B in FY2025. In FY2025, operating margin was -5.7% and net margin was -14.0%. For the trailing twelve months, revenue reached $70.60B with an operating margin of 17.3% and a profit margin of -7.8%. In the latest quarter ended June 30, 2026, quarterly revenue grew 21.6% year-over-year, while quarterly earnings increased 107.2% year-over-year.

As of June 30, 2026, Braskem held $5.93B in cash and short-term investments against total debt of $68.30B, resulting in net debt of $62.37B. Total assets stood at $79.24B, while shareholders' equity was -$12.59B, reflecting negative equity. The company reported a current ratio of 0.77. Operating cash flow was -$4.09B in FY2025, and free cash flow was -$7.16B after capital expenditures of $3.07B. Over a 5-year period, the share count changed by 0.1%.

With a market cap of $375.1M and an enterprise value of $12.83B, Braskem trades at a forward P/E of 9.8x, compared to 13.4x for the median of its US-listed Basic Materials peers. Its EV/EBITDA stands at 5.8x versus the peer median of 10.5x, and its EV/revenue is 0.9x. The stock carries a price-to-book ratio of 181.0x and price-to-sales of 0.0x. Over the past year, BAK returned -30.5% compared to 16.8% for the S&P 500, and over five years it returned -90.6% versus 83.0% for the S&P 500.

Wall Street coverage consists of 0 Strong Buy, 0 Buy, 3 Hold, 1 Sell, and 2 Strong Sell ratings. The mean price target is $1.90, which is 14.5% above the last close of $1.66. For the fiscal year ending December 31, 2026, consensus estimates project an EPS of $0.53 on revenue of $75.98B. For the following fiscal year, analysts estimate an EPS of -$1.08 and revenue of $79.33B. Braskem beat EPS estimates in 2 of the last 4 quarters, and its next earnings date is November 10, 2026.

This page is an AI-written research summary of Braskem S.A. (BAK). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: BAK income statement, BAK balance sheet, BAK key metrics, BAK analyst forecast, BAK chart. See the BAK stock overview for the latest quote and news.